Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer
Journal of Clinical Oncology Nov 09, 2017
Xie W et al. -Adjuvant therapy for intermediate-and high-risk localized prostate cancer decreases the death rate. Metastasis-free survival was shown to be a suitable surrogate for overall survival for localized prostate cancer.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
